Caregiver burden, quality of life, and psychosocial outcomes among informal caregivers of patients with glioma: A systematic review and meta-analysis
Open accessAbstract
Objective: Informal caregivers of people with glioma frequently provide complex, long-term support in the context of neurological, cognitive and behavioural impairment, which may adversely affect caregiver burden, quality of life (QoL), and broader psychosocial wellbeing, including anxiety, depression, and distress. We synthesised evidence on caregiver burden and psychosocial outcomes among caregivers of patients with glioma, and compared outcomes with caregivers of other cancers where data permitted. Methods: We conducted a systematic review and meta-analysis in accordance with PRISMA 2020. PubMed, Embase, Scopus, PsycINFO and the Cochrane Library were searched from inception to the final search date. Eligible studies reported caregiver burden, QoL, anxiety, depression and/or distress among caregivers of patients with glioma. For single-group analyses, pooled prevalences of burden, anxiety, depression and distress were estimated using random-effects meta-analysis of proportions (Freeman-Tukey transformation). For comparative analyses, standardized mean differences (SMDs) were pooled using random-effects inverse-variance models (DerSimonian-Laird) comparing caregivers of patients with glioma with caregivers of other cancers. Results: Ten studies were included. Clinically significant caregiver burden was common (pooled prevalence = 60%). Pooled prevalences of depression and anxiety were 35% and 36%, respectively, while distress was high (68%). Comparative meta-analysis (3 studies; 710 participants) showed no statistically significant difference in caregiver QoL between glioma and other-cancer caregiver groups (SMD = -0.21). Heterogeneity was substantial across outcomes. Conclusions: Informal caregivers of patients with glioma experience substantial psychosocial morbidity, including high distress, frequent burden, and common anxiety and depressive symptoms. Routine caregiver assessment and integrated caregiver-focused supportive care should be embedded in neuro-oncology pathways.
AI snapshot
Written from the paper’s full text.
TL;DR
This systematic review and meta-analysis found that informal caregivers of patients with glioma experience substantial psychosocial morbidity, especially high distress, burden, anxiety, and depressive symptoms. Comparative data did not show a statistically significant difference in caregiver quality of life between glioma and other-cancer caregiver groups.
Key findings
- Pooled prevalence of clinically significant caregiver burden was 60% (95% CI 35%–83%) across 3 studies, with individual estimates from 33% to 75% and substantial heterogeneity (I² = 83.46%).
- Pooled prevalences were 35% for depressive symptoms (95% CI 14%–60%; 6 studies), 36% for anxiety (95% CI 19%–55%; 4 studies), and 68% for psychological distress (95% CI 53%–82%; 3 studies).
- Sensitivity analyses excluding high-risk-of-bias studies changed depression from 35% to 21%, distress from 68% to 61%, and anxiety from 36% to 40%.
- Comparative meta-analysis of caregiver QoL (3 studies; 710 participants) showed no statistically significant difference between glioma caregivers and other-cancer caregivers (SMD = −0.21, 95% CI −1.15 to 0.72; P = 0.655), with considerable heterogeneity (I² = 96.0%).
Methods
- Systematic review and meta-analysis conducted per PRISMA 2020; databases searched from inception to January 2026: PubMed, Embase, Scopus, PsycINFO, and Cochrane Library.
- Ten studies were included, mostly of caregivers of high-grade glioma/glioblastoma patients; eligible outcomes were caregiver burden, QoL, anxiety, depression, and psychological distress.
- Single-group prevalences were pooled using random-effects meta-analysis of proportions with Freeman–Tukey transformation; comparative QoL used random-effects inverse-variance SMDs (DerSimonian–Laird); risk of bias assessed with Newcastle–Ottawa Scale or adapted NOS.
Limitations
- The review was not prospectively registered in PROSPERO because registration could not be completed due to platform service limitations; only 10 studies met eligibility criteria, and some pooled analyses were based on only 3 studies.
- Study quality was mixed, with 5 low, 2 moderate, and 3 high risk-of-bias studies; sensitivity analyses excluding high-risk studies changed some estimates, especially depressive symptoms.
- Heterogeneity was significant across most outcomes, likely due to differences in study design, caregiver population, tumour grade, disease phase, care setting, outcome instruments, and non-uniform thresholds; the small number of studies limited subgroup analyses.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
23 of 37 cited sources checked · 5 supported · 0 flagged · accuracy not yet measured
- Premisecitation
Caregiving in glioma differs from many other cancer types because disease often produces early neuro-oncological symptoms in patients that can disrupt personality, behaviour, communication, and functional independence.
“Caregiving in glioma differs from many other cancer types because disease often produces early neuro-oncological symptoms in patients that can disrupt personality, behaviour, communication, and functional independence.5”
Quote in the paperSubstantial claim1 of 1 sources checked- cites [5] Baddeley, 2025, Well-being and coping: key aspects of unmet need of people living with glioma, Neuro-Oncol Pract source
The Introduction (page not specified) says glioma care needs differ from those of other cancers particularly because of neurocognitive impacts. Results, Themes 1 and 3 (pages not specified), describe effects on speech, executive functioning, mobility, independence, and caregivers. Our copy does not establish that these symptoms often arise early, and it does not clearly describe personality or behavioural disruption as such. (LLM, conf=0.86)
Experimental — accuracy not yet measured
- Interpretationown data
The inconsistent direction of study-level effects indicates that "other cancer" is not a uniform comparator category.
“also indicates that “other cancer” is not a uniform comparator category.29”
Quote in the paperSubstantial claim1 of 1 sources checked- cites [29] 2009, Abstracts from the 2009 joint meeting of the society for neuro-oncology (SNO) and the American association of neurological surgeons/congress of neurological surgeons (AANS/CNS) section on tumors, Neuro Oncol source
The Results (p. 2) describe two virtual-reality surgical simulation scenarios, not comparisons among cancer groups. Searches for inconsistent study-level effects and an “other cancer” comparator found no passage addressing either point in our copy. (LLM, conf=0.76)
Experimental — accuracy not yet measured
- Interpretationreasoning
The inconsistent direction of study-level effects in this review is compatible with the interpretation that glioma caregivers may experience a distinctive form of burden.
“The inconsistent direction of study-level effects in this review is compatible with that interpretation”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites [29] 2009, Abstracts from the 2009 joint meeting of the society for neuro-oncology (SNO) and the American association of neurological surgeons/congress of neurological surgeons (AANS/CNS) section on tumors, Neuro Oncol source
The Introduction and Results (p. 2) discuss a virtual-reality simulator for brain tumor surgery, not caregiver burden. Searches for glioma caregivers, caregiver burden, and inconsistent study-level effects found no passage addressing the claimed interpretation. (LLM, conf=0.77)
Experimental — accuracy not yet measured
- Premisecitation
Across brain cancer more broadly, qualitative synthesis indicates that supportive care experiences are shaped by persistent informational, psychosocial, and practical unmet needs for both patients and informal caregivers, with gaps spanning communication, access to services, and navigation of palliative and rehabilitation resources.
“Across brain cancer more broadly, qualitative synthesis indicates that supportive care experiences are shaped by persistent informational, psychosocial, and practical unmet needs for both patients and informal caregivers, with gaps spanning communication, access to services, and navigation of palliative and rehabilitation resources.15”
Quote in the paperSubstantial claim1 of 1 sources checked- cites [15] Paterson, 2024, What are the experiences of supportive care in people affected by brain cancer and their informal caregivers: a qualitative systematic review, J Cancer Surviv source
Split into 2 atoms — 1 confirmed, 1 partially supported, 0 disputed, 0 misattributed, 0 unverifiable. Expand the claim to see per-atom verdicts.
Experimental — accuracy not yet measured
- Premisecitation
Neuro-oncology literature suggests that glioma caregivers may experience a particularly distinctive form of burden because patient cognitive, behavioural, and communication changes can disrupt relationships, shared decision-making, and daily family functioning in ways that are less prominent in many other cancers.
“Conversely, neuro-oncology literature suggests that glioma caregivers may experience a particularly distinctive form of burden because patient cognitive, behavioural, and communication changes can disrupt relationships, shared decision-making, and daily family functioning in ways that are less prominent in many other cancers.”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites [29] 2009, Abstracts from the 2009 joint meeting of the society for neuro-oncology (SNO) and the American association of neurological surgeons/congress of neurological surgeons (AANS/CNS) section on tumors, Neuro Oncol source
Split into 2 atoms — 0 confirmed, 0 partially supported, 0 disputed, 0 misattributed, 2 unverifiable. Expand the claim to see per-atom verdicts.
Experimental — accuracy not yet measured
- Premisecitation
Caregiver QoL and support needs may be particularly noticeable during transitions in care progression, treatment failure, and end-of-life periods when symptom burden escalates or care coordination intensifies.
“Caregiver QoL and support needs may be particularly noticeable during transitions in care progression, treatment failure, and end-of-life periods when symptom burden escalates or care coordination intensifies.12”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites [12] Song, 2016, Advance care planning in patients with primary malignant brain tumors: a systematic review, Front Oncol source
The Results (Synthesis of Results; page unavailable) report generally low caregiver QoL during the illness trajectory and discuss caregivers’ experiences of end-of-life care and transitions between healthcare settings. The Results (Study Characteristics; page unavailable) describe increasing family-support and care intensity during disease progression and at end of life. The review does not specifically identify treatment failure as a period of heightened caregiver need or show that escalating symptoms or care coordination make caregiver QoL needs more noticeable. (LLM, conf=0.84)
Experimental — accuracy not yet measured
- Findingown data
The pooled prevalence of distress among caregivers of patients with glioma was 68%.
“while distress was high (68%).”
Quote in the paperNot a substantial claim - Findingown data
The pooled prevalence of anxiety among caregivers of patients with glioma was 36%.
“Pooled prevalences of depression and anxiety were 35% and 36%, respectively”
Quote in the paperNot a substantial claim - Findingown data
The pooled prevalence of depression among caregivers of patients with glioma was 35%.
“Pooled prevalences of depression and anxiety were 35% and 36%, respectively”
Quote in the paperSubstantial claim - Findingown data
Ten studies were included in the review.
“Ten studies were included.”
- Also stated in: § Search results · plain
“The remaining 10 studies were included in the review (Fig. 1).10,13,14,19, 20, 21, 22, 23, 24, 25”
Quote in the paperNot a substantial claim - Also stated in: § Search results · plain
- Findingown data
In the single-group meta-analysis of caregiver burden (3 studies), individual study estimates ranged from 33% to 75%.
“Individual study estimates ranged from 33% to 75%.”
Quote in the paperNot a substantial claim - Findingown data
Comparative meta-analysis of 3 studies (710 participants) showed no statistically significant difference in caregiver QoL between glioma and other-cancer caregiver groups (SMD = −0.21).
“Comparative meta-analysis (3 studies; 710 participants) showed no statistically significant difference in caregiver QoL between glioma and other-cancer caregiver groups (SMD = −0.21).”
Quote in the paperSubstantial claim - Findingnone given
Heterogeneity was substantial across outcomes.
“Heterogeneity was substantial across outcomes.”
Quote in the paperNot a substantial claim - Findingown data
There was substantial heterogeneity across studies for caregiver burden (I2 = 83.46%, χ2 = 12.09, df = 2, P = 0.002), with between-study variance τ2 = 0.16.
“There was substantial heterogeneity across studies (I2 = 83.46%, χ2 = 12.09, df = 2, P = 0.002), with between-study variance τ2 = 0.16.”
Quote in the paperNot a substantial claim - Findingown data
The pooled prevalence of clinically significant caregiver burden among glioma caregivers was 60% (95% CI 35% to 83%).
“Clinically significant caregiver burden was common (pooled prevalence = 60%).”
- Also stated in: § Caregiver burden · plain
“the pooled prevalence of clinically significant burden among glioma caregivers was 60% (random-effects; 95% CI 35% to 83%) (Fig. 2).”
Quote in the paperSubstantial claim - Also stated in: § Caregiver burden · plain
- Findingown data
Across 6 studies, the pooled prevalence of depressive symptoms among caregivers of patients with glioma was 35% (random-effects; 95% CI 14% to 60%).
“Across 6 studies, the pooled prevalence of depressive symptoms among caregivers of patients with glioma was 35% (random-effects; 95% CI 14% to 60%) (Fig. 4).”
Quote in the paperSubstantial claim- Rests on an assumption: The different screening instruments and thresholds used across included studies measure the same underlying constructs sufficiently to be pooled.
- Findingown data
Between-study heterogeneity for the caregiver quality-of-life comparison was considerable (Q = 49.45, df = 2, P < 0.001; I2 = 96.0%).
“Between-study heterogeneity was considerable (Q = 49.45, df = 2, P < 0.001; I2 = 96.0%), indicating substantial variability across included studies.”
Quote in the paperNot a substantial claim - Findingown data
After excluding studies judged to be at high risk of bias, the pooled prevalence of anxiety increased slightly from 36% to 40% (95% CI 31% to 50%).
“After excluding studies judged to be at high risk of bias, the pooled prevalence increased slightly from 36% to 40% (95% CI 31% to 50%) (Supplementary Fig. S2)”
Quote in the paperNot a substantial claim- Rests on an assumption: The different screening instruments and thresholds used across included studies measure the same underlying constructs sufficiently to be pooled.
- Findingown data
In a comparative meta-analysis of 3 studies comprising 710 participants, the pooled random-effects SMD showed no statistically significant difference in quality of life between caregivers of patients with glioma and caregivers of patients with other tumours (SMD = −0.21, 95% CI −1.15 to 0.72; z = −0.45, P = 0.655).
“The pooled SMD (random-effects, DerSimonian–Laird) showed no statistically significant difference in QoL between caregivers of patients with glioma and caregivers of other tumour patients (SMD = −0.21, 95% CI −1.15 to 0.72; z = −0.45, P = 0.655)”
Quote in the paperSubstantial claim - Findingown data
The most prominent signal from pooled data was the high prevalence of distress.
“The most prominent signal from pooled data was the high prevalence of distress”
Quote in the paperSubstantial claim - Findingown data
After excluding studies judged to be at high risk of bias, the pooled prevalence of depressive symptoms decreased from 35% to 21% (95% CI 4% to 46%).
“After excluding studies judged to be at high risk of bias, the pooled prevalence decreased from 35% to 21% (95% CI 4% to 46%) (Supplementary Fig. S1).”
Quote in the paperSubstantial claim- Rests on an assumption: The different screening instruments and thresholds used across included studies measure the same underlying constructs sufficiently to be pooled.
- Findingown data
Heterogeneity across studies of depressive symptoms was very high (I2 = 94.02%, χ2 = 83.57, df = 5, P = 0.003; τ2 = 0.34).
“There was very high heterogeneity across studies (I2 = 94.02%, χ2 = 83.57, df = 5, P = 0.003), with between-study variance τ2 = 0.34.”
Quote in the paperNot a substantial claim - Findingown data
A substantial proportion of caregivers of patients with glioma experience clinically significant burden.
“With respect to caregiver burden, pooled prevalence indicated that a substantial proportion of caregivers experience clinically significant burden”
Quote in the paperSubstantial claim- Rests on an assumption: The different screening instruments and thresholds used across included studies measure the same underlying constructs sufficiently to be pooled.
- Findingown data
Heterogeneity for anxiety was substantial (I2 = 78.16%, χ2 = 13.74, df = 3, P < 0.001; τ2 = 0.11).
“Heterogeneity was substantial (I2 = 78.16%, χ2 = 13.74, df = 3, P < 0.001), with between-study variance τ2 = 0.11.”
Quote in the paperNot a substantial claim - Findingown data
After excluding studies judged to be at high risk of bias, the pooled prevalence of psychological distress decreased from 68% to 61% (95% CI 53% to 69%).
“After excluding studies judged to be at high risk of bias, the pooled prevalence decreased from 68% to 61% (95% CI 53% to 69%) (Supplementary Fig. S3).”
Quote in the paperNot a substantial claim- Rests on an assumption: The different screening instruments and thresholds used across included studies measure the same underlying constructs sufficiently to be pooled.
- Findingown data
Individual study effects for the caregiver quality-of-life comparison were inconsistent in direction (SMD range: −1.06 to 0.61).
“Individual study effects were inconsistent in direction (SMD range: −1.06 to 0.61).”
Quote in the paperNot a substantial claim - Findingown data
Heterogeneity for psychological distress was substantial (I2 = 73.66%, χ2 = 7.59, df = 2, P = 0.02; τ2 = 0.05).
“Heterogeneity was substantial (I2 = 73.66%, χ2 = 7.59, df = 2, P = 0.02), with between-study variance τ2 = 0.05.”
Quote in the paperNot a substantial claim - Findingown data
In a pooled single-group analysis of 4 studies, the prevalence of clinically significant anxiety among caregivers of patients with glioma was 36% (random-effects; 95% CI 19% to 55%).
“In the pooled single-group analysis of anxiety among caregivers of patients with glioma (4 studies), the prevalence of clinically significant anxiety was 36% (random-effects; 95% CI 19% to 55%) (Fig. 5).”
Quote in the paperNot a substantial claim- Rests on an assumption: The different screening instruments and thresholds used across included studies measure the same underlying constructs sufficiently to be pooled.
- Findingown data
In a meta-analysis of 3 studies, the pooled prevalence of clinically significant psychological distress among caregivers of patients with glioma was 68% (random-effects; 95% CI 53% to 82%).
“In the meta-analysis of psychological distress among caregivers of patients with glioma (3 studies), the pooled prevalence of clinically significant distress was 68% (random-effects; 95% CI 53% to 82%) (Fig. 6).”
Quote in the paperSubstantial claim- Rests on an assumption: The different screening instruments and thresholds used across included studies measure the same underlying constructs sufficiently to be pooled.
- Findingnone given
Distress had the highest burden amongst the outcomes assessed in this review.
“As distress had the highest burden amongst the outcomes assessed in this review”
Quote in the paperSubstantial claim - Findingreasoning
Heterogeneity was significant across most of the outcomes.
“Heterogeneity was significant across most of the outcomes.”
Quote in the paperNot a substantial claim - Study design and conductown data
Sensitivity analysis excluding high-risk-of-bias studies was not feasible for caregiver burden because two of the three studies contributing to this pooled estimate were judged to be at high risk of bias.
“Sensitivity analysis excluding high-risk-of-bias studies was not feasible for caregiver burden, because two of the three studies contributing to this pooled estimate were judged to be at high risk of bias, leaving insufficient studies for a meaningful re-analysis.”
Quote in the paperNot a substantial claim - Interpretationown data
Although the estimate was slightly lower, clinically significant distress remained highly prevalent among caregivers of patients with glioma.
“Although the estimate was slightly lower, clinically significant distress remained highly prevalent among caregivers of patients with glioma.”
Quote in the paperSubstantial claim - Premisecitation
Qualitative data depict caregiving as an isolating role characterised by feeling unprepared, under-informed, and insufficiently supported by health care systems.
“Qualitative data similarly depict caregiving as an isolating role characterised by feeling unprepared, under-informed, and insufficiently supported by health care systems.13”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [13] Gulino, 2024, Caregivers' perspective and burden of the end-of-life phase of patients with glioblastoma: a multicenter retrospective study, World Neurosurg source
- Study design and conductnone given
Depression, anxiety, and distress were assessed using different screening instruments across included studies.
“depression, anxiety, and distress were assessed using different screening instruments across included studies.”
Quote in the paperSubstantial claim - Interpretationown data
The reduction in pooled depressive symptoms after excluding high-risk-of-bias studies suggests that inclusion of high-risk-of-bias studies may have contributed to a higher primary pooled estimate for depressive symptoms.
“This reduction suggests that inclusion of high-risk-of-bias studies may have contributed to a higher primary pooled estimate for depressive symptoms.”
Quote in the paperSubstantial claim - Interpretationreasoning
Heterogeneity in caregiver burden may have been amplified by differences in the instruments used to assess caregiver burden and by variation in how clinically significant burden was operationalized across studies.
“In addition, heterogeneity may have been amplified by differences in the instruments used to assess caregiver burden and by variation in how clinically significant burden was operationalized across studies.”
Quote in the paperNot a substantial claim - Interpretationreasoning
Many caregivers of patients with glioma face meaningful constraints on their daily functioning and role capacity.
“implying that many caregivers face meaningful constraints on their daily functioning and role capacity.”
Quote in the paperSubstantial claim - Study design and conductown data
None of the three studies in the caregiver quality-of-life comparison had high risk of bias.
“None of the three studies had high risk of bias and hence, sensitivity analysis was not applicable.”
Quote in the paperNot a substantial claim - Study design and conductnone given
The number of included studies was limited overall.
“the number of included studies was limited overall”
Quote in the paperSubstantial claim - Interpretationcitation
The absence of a pooled difference in quality of life may reflect that caregiving for other advanced cancers can also be profoundly taxing when care needs are intense.
“In that sense, the absence of a pooled difference may reflect the fact that caregiving for other advanced cancers can also be profoundly taxing when care needs are intense.20,28”
Quote in the paperNot a substantial claim0 of 2 sources checked - Study design and conductown data
Several outcome-specific analyses were based on only a small number of studies.
“several outcome-specific analyses were based on only a small number of studies.”
Quote in the paperSubstantial claim - Study design and conductown data
A small number of studies available for individual outcomes limited the ability to conduct subgroup analysis for factors like glioma grade, active treatment or end-of-life care, caregiver relationship, and instrument type.
“Finally, a small number of studies available for individual outcomes limited our ability to conduct subgroup analysis for factors like glioma grade, active treatment or end of life care, caregiver relationship, and instrument type.”
Quote in the paperNot a substantial claim - Study design and conductown data
Only 10 studies met eligibility criteria.
“only 10 studies met eligibility criteria”
Quote in the paperSubstantial claim - Study design and conductown data
Pooled analysis of some outcomes was based on only three studies.
“pooled analysis of some outcomes was based on only three studies.”
Quote in the paperSubstantial claim - Study design and conductreasoning
Clinically significant outcomes were not defined using identical thresholds across the studies.
“Clinically significant outcomes were not defined using identical thresholds across the studies.”
Quote in the paperSubstantial claim - Interpretationreasoning
Measurement variability could have contributed to the high heterogeneity observed in the pooled analysis.
“This measurement variability could have contributed to the high heterogeneity observed in the pooled analysis.”
Quote in the paperNot a substantial claim - Interpretationown data
High heterogeneity and inconsistent direction of study-level effects suggest that differences between glioma caregivers and other cancer caregivers may depend on comparator population and clinical contexts.
“High heterogeneity and inconsistent direction of study level effects suggest that differences may depend on comparator population and clinical contexts.”
Quote in the paperSubstantial claim - Interpretationreasoning
These methodological limitations may have influenced pooled prevalence estimates.
“These limitations are relevant because they may have influenced pooled prevalence estimates.”
Quote in the paperSubstantial claim
- Classified as probably not a substantial claim. 25
- May combine two claims. 35
Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
PremisecitationCaregiver distress arises not only from practical care tasks, but also from prognostic uncertainty, the need for vigilance regarding neurological deterioration, and the psychological impact of witnessing progressive cognitive and functional loss in the patient.
“These findings align with broader neuro-oncology literature in which caregiver distress arises not only from practical care tasks, but also from prognostic uncertainty, the need for vigilance regarding neurological deterioration, and the psychological impact of witnessing progressive cognitive and functional loss in the patient.11”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites [11] Long, 2016, Carers of patients with high-grade glioma report high levels of distress, unmet needs, and psychological morbidity during patient chemoradiotherapy, Neuro-Oncol Pract source
Split into 2 atoms — 0 confirmed, 2 partially supported, 0 disputed, 0 misattributed, 0 unverifiable. Expand the claim to see per-atom verdicts.
Experimental — accuracy not yet measured
May combine two claims.
PremisecitationConsistent caregiver burden might contribute to reduction in caregiver health-related quality of life, increased anxiety and depressive symptoms, sleep disruption, and reduced participation in employment and social activities.
“Consistent caregiver burden might contribute to reduction in caregiver health-related quality of life (QoL), increased anxiety and depressive symptoms, sleep disruption, and reduced participation in employment and social activities.”
Quote in the paperSubstantial claim1 of 1 sources checked- cites [8] Sakurada, 2025, Mental health status and associated factors of caregivers of patients with malignant brain tumors, J Neuro Oncol source
The Introduction says caregiving demands can affect caregivers’ quality of life and identifies caregiver burden as associated with depression and anxiety. The Discussion likewise links burden with depression and reports lower social functioning among caregivers. The paper does not establish that burden causes sleep disruption or reduced participation in employment and social activities; it mentions sleep quality as a factor related to depression, not as an outcome of burden. (LLM, conf=0.85)
Experimental — accuracy not yet measured
Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
PremisecitationSimilar work in glioblastoma caregivers has highlighted that burden is not uniform across clinical settings and might vary according to treatment phase and patient clinical characteristics.
“Similar work in glioblastoma caregivers has also highlighted that burden is not uniform across clinical settings and might vary according to treatment phase and patient clinical characteristics.10”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites [10] Au, 2022, Caregiver burden by treatment and clinical characteristics of patients with glioblastoma, Support Care Cancer source
The Results and Conclusion report that caregiver burden differs with patient clinical characteristics, including performance status and confusion. The Patient demographics section includes caregivers at different treatment stages, but the paper does not establish that burden varies by treatment phase; its Discussion notes that the one-time survey cannot reflect changes over the course of caregiving. No page numbers were available in our copy. (LLM, conf=0.86)
Experimental — accuracy not yet measured
May combine two claims.
PremisecitationPrior caregiver research in cancer populations demonstrates prevalence estimates that vary widely depending on tools and thresholds, but consistently indicate clinically meaningful symptom levels.
“Prior caregiver research in cancer populations demonstrates prevalence estimates that vary widely depending on tools and thresholds, but consistently indicate clinically meaningful symptom levels.30,31”
Quote in the paperNot a substantial claim2 of 2 sources checked- cites [30] Chen, 2021, The role of informal caregivers for patients with glioma: a systematic review and meta-synthesis of qualitative studies, Ann Transl Med source
The Results (Findings of the review; page unavailable) describe anxiety, worry, fear, and distress among caregivers of people with glioma. But this qualitative review does not report caregiver symptom-prevalence estimates, compare measurement tools or thresholds, or establish that symptoms reached clinically meaningful levels. (LLM, conf=0.82)
Experimental — accuracy not yet measured - cites [31] Pan, 2022, Systematic review and meta-analysis of prevalence of depression among caregivers of cancer patients, Front Psychiatr source
May combine two claims.
InterpretationcitationThe pooled burden prevalence in this review is broadly consistent with prior neuro-oncology literature, while the heterogeneity mirrors the diversity of caregiving contexts previously described.
“The pooled burden prevalence in this review is broadly consistent with that literature, while the heterogeneity mirrors the diversity of caregiving contexts previously described.10,27”
Quote in the paperNot a substantial claim1 of 2 sources checked- cites [10] Au, 2022, Caregiver burden by treatment and clinical characteristics of patients with glioblastoma, Support Care Cancer source
The Conclusion (page unavailable) says that glioblastoma caregiver–patient dyads are not all alike, and the Discussion describes differences in caregiver experience linked to patient characteristics. This supports the point about diverse caregiving contexts. The paper does not compare this review’s pooled burden prevalence with prior literature or assess the review’s statistical heterogeneity. (LLM, conf=0.86)
Experimental — accuracy not yet measured - cites [27] Fortunato, 2020, Caregiver perceptions of end-of-life care in patients with high-grade glioma, Neuro-Oncol Pract source
Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
PremisecitationEarlier reports in neuro-oncology often describe moderate-to-severe burden levels and identify patient functional dependence and neuropsychiatric symptoms as key correlates.
“When considering caregiver burden, earlier reports in neuro-oncology often describe moderate-to-severe burden levels and identify patient functional dependence and neuropsychiatric symptoms as key correlates.26,27”
Quote in the paperNot a substantial claim1 of 2 sources checked- cites [26] Saria, 2017, The hidden morbidity of cancer: burden in caregivers of patients with brain metastases, Nurs Clin North Am source
In “Primary Demands of Caregiving” (page unavailable), the paper reports that functional status affected one caregiver-burden subscale in a study of primary brain tumors, while neuropsychiatric status affected every subscale. It does not establish the claimed moderate-to-severe burden levels in neuro-oncology; searches for that severity description found no supporting passage. (LLM, conf=0.84)
Experimental — accuracy not yet measured - cites [27] Fortunato, 2020, Caregiver perceptions of end-of-life care in patients with high-grade glioma, Neuro-Oncol Pract source
May combine two claims.
PremisecitationEmpirical studies in patients with glioma suggest that caregiver burden is common and clinically meaningful.
“Empirical studies in patients with glioma suggest that caregiver burden is common and clinically meaningful.6, 7, 8, 9, 10”
Quote in the paperSubstantial claim3 of 5 sources checked- cites [6] Clifton, 2021, The impact of functional dependence and related surgical complications on postoperative mortality, J Med Syst source
The Discussion addresses functional dependence, surgical complications, and postoperative mortality, not caregiver burden. Searches for glioma, caregivers, and clinically meaningful burden found no passage in our copy addressing the claim. (LLM, conf=0.76)
Experimental — accuracy not yet measured - cites [7] Coolbrandt, 2015, Family caregivers of patients with a high-grade glioma: a qualitative study of their lived experience and needs related to professional care, Cancer Nurs source
- cites [8] Sakurada, 2025, Mental health status and associated factors of caregivers of patients with malignant brain tumors, J Neuro Oncol source
- cites [9] Li, 2022, Caregiver burden and influencing factors among family caregivers of patients with glioma: a cross-sectional survey, J Clin Neurosci source
- cites [10] Au, 2022, Caregiver burden by treatment and clinical characteristics of patients with glioblastoma, Support Care Cancer source
May combine two claims.
InterpretationcitationCaregiver burden and QoL are core outcomes in glioma care, reflecting both the intensity of caregiving tasks and the broader psychosocial ecology in which caregiving occurs.
“Collectively, these data suggest that caregiver burden and QoL are core outcomes in glioma care, reflecting both the intensity of caregiving tasks and the broader psychosocial ecology in which caregiving occurs.15”
Quote in the paperSubstantial claim1 of 1 sources checked- cites [15] Paterson, 2024, What are the experiences of supportive care in people affected by brain cancer and their informal caregivers: a qualitative systematic review, J Cancer Surviv source
May combine two claims.
InterpretationcitationWhen compared to previous literature on caregivers of other oncology patients, the prevalence of caregiver burden, anxiety, depression, and distress found in this review appears clinically significant and, in some ways, might be comparable to or higher than estimates reported in mixed cancer caregivers.
“When compared to previous literature on caregivers of other oncology patients, the prevalence of caregiver burden, anxiety, depression, and distress found in this review appears clinically significant and, in some ways, might be comparable to or higher than estimates reported in mixed cancer caregivers.32, 33”
Quote in the paperSubstantial claim1 of 2 sources checked- cites [32] Forst, 2022, Factors associated with psychological distress in caregivers of patients with malignant gliomas, Support Care Cancer source
- cites [33] Molassiotis, 2022, Understanding and supporting informal cancer caregivers, Curr Treat Options Oncol source
The paper’s “Impact of caregiving on informal cancer caregivers” section describes burden, anxiety, depressive symptoms, and psychological distress among cancer caregivers. It does not provide prevalence estimates for those outcomes, so it cannot substantiate the citing review’s comparison of rates with mixed-cancer caregiver estimates. No page number is available in our copy. (LLM, conf=0.82)
Experimental — accuracy not yet measured
Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
PremisecitationCaregivers of patients with advanced forms of cancer are known to have impaired quality of life and higher psychological morbidities.
“Caregivers of patients with advanced forms of cancer are known to have impaired QoL and higher psychological morbidities.”
Quote in the paperNot a substantial claim1 of 2 sources checked- cites [32] Forst, 2022, Factors associated with psychological distress in caregivers of patients with malignant gliomas, Support Care Cancer source
- cites [33] Molassiotis, 2022, Understanding and supporting informal cancer caregivers, Curr Treat Options Oncol source
The ‘Impact of caregiving on informal cancer caregivers’ section says that caregiving can jeopardize quality of life and cause emotional distress; it also reports higher anxiety and depression after some caregivers are bereaved. These passages support the general point, but they do not establish both outcomes specifically for caregivers of patients with advanced cancer. Page numbers were not provided in our copy. (LLM, conf=0.84)
Experimental — accuracy not yet measured
May combine two claims.
InterpretationcitationThe overall pattern of findings aligns with the broader psycho-oncology literature demonstrating elevated caregiver burden and psychological morbidity among caregivers of cancer patients, while also reflecting features that are particularly salient in neuro-oncology.
“The overall pattern of findings aligns with the broader psycho-oncology literature demonstrating elevated caregiver burden and psychological morbidity among caregivers of cancer patients, while also reflecting features that are particularly salient in neuro-oncology.11,30”
Quote in the paperSubstantial claim2 of 2 sources checked- cites [11] Long, 2016, Carers of patients with high-grade glioma report high levels of distress, unmet needs, and psychological morbidity during patient chemoradiotherapy, Neuro-Oncol Pract source
- cites [30] Chen, 2021, The role of informal caregivers for patients with glioma: a systematic review and meta-synthesis of qualitative studies, Ann Transl Med source
Split into 2 atoms — 1 confirmed, 1 partially supported, 0 disputed, 0 misattributed, 0 unverifiable. Expand the claim to see per-atom verdicts.
Experimental — accuracy not yet measured
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationThe impaired quality of life and higher psychological morbidities among caregivers of patients with advanced cancer are because symptom burden, treatment intensity, and end-of-life care needs for the patients are high.
“This is because symptom burden, treatment intensity, and end-of-life care needs for the patients are high.32,33”
Quote in the paperNot a substantial claim1 of 2 sources checked- cites [32] Forst, 2022, Factors associated with psychological distress in caregivers of patients with malignant gliomas, Support Care Cancer source
- cites [33] Molassiotis, 2022, Understanding and supporting informal cancer caregivers, Curr Treat Options Oncol source
The sections on interpersonal factors and the impact of caregiving (page not provided) link patients’ care demands to caregiver burden and quality of life, and describe distress during chemotherapy and end-of-life transitions. They do not establish that high patient symptom burden, treatment intensity, and end-of-life care needs together explain impaired quality of life and greater psychological morbidity specifically among caregivers of patients with advanced cancer. (LLM, conf=0.82)
Experimental — accuracy not yet measured
Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
PremisecitationPrior studies in cancer caregiving consistently show that informal caregivers experience higher rates of anxiety, depressive symptoms, and reduced quality of life compared with population norms, with burden influenced by caregiving intensity, financial toxicity, and perceived lack of support.
“Prior studies in cancer caregiving consistently show that informal caregivers experience higher rates of anxiety, depressive symptoms, and reduced QoL compared with population norms, with burden influenced by caregiving intensity, financial toxicity, and perceived lack of support.33”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites [33] Molassiotis, 2022, Understanding and supporting informal cancer caregivers, Curr Treat Options Oncol source
Split into 2 atoms — 1 confirmed, 1 partially supported, 0 disputed, 0 misattributed, 0 unverifiable. Expand the claim to see per-atom verdicts.
Experimental — accuracy not yet measured
May combine two claims.
Interpretationown dataInformal caregivers of patients with glioma experience substantial psychosocial morbidity, including high distress, frequent burden, and common anxiety and depressive symptoms.
“Informal caregivers of patients with glioma experience substantial psychosocial morbidity, including high distress, frequent burden, and common anxiety and depressive symptoms.”
Quote in the paperSubstantial claimMay combine two claims.
Study design and conductown dataOverall risk of bias rating showed that five studies were rated low risk, two moderate, and three high risk of bias.
“Overall risk of bias rating showed that five studies rated to have low risk, two moderate, and three high risk of bias.”
Quote in the paperNot a substantial claimMay combine two claims.
PremisecitationPrevious studies have shown that a significant number of family caregivers of patients with glioma report moderate to severe levels of burden, with respect to reduction in sleep duration and increased anxiety and depressive symptoms.
“Previous studies have shown that a significant number of family caregivers of patients with glioma report moderate to severe levels of burden, with respect to reduction in sleep duration and increased anxiety and depressive symptoms.9”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [9] Li, 2022, Caregiver burden and influencing factors among family caregivers of patients with glioma: a cross-sectional survey, J Clin Neurosci source
Classified as probably not a substantial claim.
Study design and conductreasoningA random-effects model was used for all meta-analyses.
“Given expected clinical and methodological heterogeneity (differences in glioma grade, treatment phase, caregiver relationship, and outcome instruments), a random-effects model was used for all meta-analyses.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductcitationRisk of bias for observational studies was assessed independently by two reviewers using the Newcastle-Ottawa Scale (NOS) for cohort/case-control studies and an adapted NOS for cross-sectional studies.
“Risk of bias for observational studies was assessed independently by two reviewers using the Newcastle–Ottawa Scale (NOS) for cohort/case–control studies and an adapted NOS for cross-sectional studies.17”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [17] Wells GA, Shea B, O’Connell D, Peterson J, Welch V, Losos M, Tugwell P. The Newcastle–Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. Ottawa: Ottawa Hospital Research Institute. Available from: https://www.ohri.ca/en/who-we-are/core-facilities-and-platforms/ottawa-methods-centre/newcastle-ottawa-scale.
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
Probably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductnone givenIf multiple time points were reported, baseline or the time point most comparable across studies was preferentially extracted.
“If multiple time points were reported, baseline or the time point most comparable across studies (typically closest to diagnosis/treatment initiation) was preferentially extracted; alternative time points were explored in sensitivity analyses when data permitted.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductnone givenSensitivity analysis was performed to assess the robustness of the results by excluding studies at high risk of bias.
“Sensitivity analysis was performed to assess the robustness of the results by excluding studies at high risk of bias.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductnone givenA prespecified hierarchy was applied when a study reported multiple eligible instruments for the same construct, prioritizing the most commonly used and validated scale in oncology caregiver research.
“If a study reported multiple eligible instruments for the same construct (e.g., two depression scales), a prespecified hierarchy was applied prioritizing the most commonly used and validated scale in oncology caregiver research; otherwise, the instrument most frequently reported across included studies was selected to avoid double-counting.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductreasoningPublication bias was assessed using a funnel plot with Egger's test for depression outcome.
“Publication bias was assessed using a funnel plot with Egger's test for depression outcome as it had a reasonable number of studies.”
Quote in the paperNot a substantial claimMay combine two claims.
Interpretationown dataPooled prevalence estimates indicate that clinically significant depressive and anxiety symptoms are frequent among glioma caregivers, reflecting a substantial mental health burden in this population.
“For depression and anxiety, pooled prevalence estimates indicate that clinically significant symptoms are frequent among glioma caregivers, reflecting a substantial mental health burden in this population.”
Quote in the paperSubstantial claim- Rests on an assumption: The different screening instruments and thresholds used across included studies measure the same underlying constructs sufficiently to be pooled.
May combine two claims.
Study design and conductown dataThe funnel plot for depression was symmetrical, indicating no clear evidence of publication bias, confirmed by a non-significant Egger's test (P = 0.699).
“Supplementary Fig. S4 shows the symmetrical funnel plot for depression indicating no clear evidence of publication bias and it was confirmed by a non-significant Egger's test (P = 0.699).”
Quote in the paperNot a substantial claimMay combine two claims.
Interpretationown dataGlioma caregiving frequently involves an intense psychological strain profile that extends beyond routine caregiving demands and is likely shaped by neuro-oncological disease characteristics.
“suggesting that glioma caregiving frequently involves an intense psychological strain profile that extends beyond routine caregiving demands and is likely shaped by neuro-oncological disease characteristics.”
Quote in the paperSubstantial claimMay combine two claims.
Interpretationown dataAcross included studies, caregiver outcomes were consistently impaired, but magnitude varied substantially by study context, measurement approach, and clinical phase.
“Across included studies, caregiver outcomes were consistently impaired, but magnitude varied substantially by study context, measurement approach, and clinical phase.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductnone givenDisagreements in risk of bias assessment were resolved by consensus or third-party adjudication.
“Disagreements were resolved by consensus or third-party adjudication.”
Quote in the paperNot a substantial claimMay combine two claims.
Interpretationown dataThe anxiety estimate remained broadly comparable and was not materially reduced after sensitivity analysis.
“indicating that the anxiety estimate remained broadly comparable and was not materially reduced after sensitivity analysis.”
Quote in the paperNot a substantial claimMay combine two claims.
Interpretationown dataPooled estimates indicate that adverse caregiver experiences are common, with a sizeable proportion reporting clinically significant burden and emotional symptoms.
“Overall, pooled estimates indicate that adverse caregiver experiences are common, with a sizeable proportion reporting clinically significant burden and emotional symptoms.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductown dataTwo reviewers independently screened titles/abstracts and full texts for eligibility.
“Two reviewers independently screened titles/abstracts for eligibility, followed by full-text screening of potentially eligible reports.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing), S4 (based). May combine two claims.
PremisecitationIn a multicentre retrospective study focusing on the last months of life in glioblastoma, caregivers reported low QoL alongside symptoms suggestive of burnout and a strong need for targeted psychological support and caregiver training.
“In a multicentre retrospective study focusing on the last months of life in glioblastoma, caregivers reported low QoL alongside symptoms suggestive of burnout and a strong need for targeted psychological support and caregiver training.”
Quote in the paperNot a substantial claimMay combine two claims.
PremisecitationMany studies outside neuro-oncology report substantial quality-of-life impairment among caregivers of advanced cancers, particularly where symptom burden, treatment intensity, and end-of-life caregiving predominate, which could narrow observed differences between tumour types.
“Many studies outside neuro-oncology report substantial QoL impairment among caregivers of advanced cancers, particularly where symptom burden, treatment intensity, and end-of-life caregiving predominate, which could narrow observed differences between tumour types.”
Quote in the paperSubstantial claim0 of 2 sources checkedProbably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
Study design and conductnone givenDiscrepancies in screening were resolved through discussion; if unresolved, a third reviewer adjudicated.
“Discrepancies were resolved through discussion; if unresolved, a third reviewer adjudicated.”
Quote in the paperNot a substantial claimMay combine two claims.
PremisecitationRecent qualitative work in glioblastoma caregivers describes overwhelming burden, challenges coping with the caregiving role, and deficiencies in caregiver support, including limited education and confusion regarding hospice and palliative pathways.
“Recent qualitative work in glioblastoma caregivers reinforces these themes, describing overwhelming burden, challenges coping with the caregiving role, and deficiencies in caregiver support, including limited education and confusion regarding hospice and palliative pathways.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductnone givenThe systematic review and meta-analysis was conducted and reported in accordance with the PRISMA 2020 statement.
“This systematic review and meta-analysis was conducted and reported in accordance with the PRISMA 2020 statement.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductnone givenTwo reviewers independently extracted data using a piloted standardized extraction form.
“Two reviewers independently extracted data using a piloted standardized extraction form.”
Quote in the paperNot a substantial claimMay combine two claims.
InterpretationreasoningAlthough the absolute severity of burden may overlap with that seen in other advanced cancer caregiving settings, the pattern and drivers of distress in glioma appear to be particularly complex.
“Thus, although the absolute severity of burden may overlap with that seen in other advanced cancer caregiving settings, the pattern and drivers of distress in glioma appear to be particularly complex.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductnone givenThe review was conducted in accordance with the PRISMA 2020 guidelines.
“Nevertheless, the review was conducted in accordance with the PRISMA 2020 guidelines”
Quote in the paperNot a substantial claimMay combine two claims.
Interpretationown dataStudy quality may have contributed to variability in some pooled estimates, particularly depressive symptoms, although the overall conclusion that glioma caregivers experience substantial psychosocial morbidity remained unchanged.
“These changes indicate that study quality may have contributed to variability in some pooled estimates, particularly depressive symptoms, although the overall conclusion that glioma caregivers experience substantial psychosocial morbidity remained unchanged.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S2 (checkable), S4 (based). May combine two claims.
InterpretationreasoningAlthough caregivers of patients with other advanced cancers also experience such burden, glioma caregiving may be unique and complex because of the combination of impact of neurological decline, cognitive and behavioural change, and rapid shifts in patient dependency.
“Although caregivers of patients with other advanced cancers also experience such burden, glioma caregiving may be unique and complex because of the combination of impact of neurological decline, cognitive and behavioural change, and rapid shifts in patient dependency.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
InterpretationreasoningHeterogeneity might be due to differences in study design, caregiver population, tumour grade, disease phase, care setting, and variability in outcome measurement.
“This might be due to differences in study design, caregiver population, tumour grade, disease phase, care setting, and variability in outcome measurement.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductnone givenThis review was not prospectively registered in PROSPERO because registration could not be completed during the study period due to service limitations on the PROSPERO platform.
“This review was not prospectively registered in PROSPERO because registration could not be completed during the study period due to service limitations on the PROSPERO platform.”
Quote in the paperNot a substantial claimMay combine two claims.
Interpretationown dataThis review suggests that caregivers of patients with glioma experience substantial psychosocial burden, characterized by high levels of distress, followed by caregiver burden, anxiety, and depressive symptoms.
“This review suggests that caregivers of patients with glioma experience substantial psychosocial burden, characterized by high levels of distress, followed by caregiver burden, anxiety, and depressive symptoms.”
Quote in the paperSubstantial claim- Rests on an assumption: The different screening instruments and thresholds used across included studies measure the same underlying constructs sufficiently to be pooled.
May combine two claims.
InterpretationreasoningA limited number of contributing studies reduces statistical power, precision, restricts the ability to explore heterogeneity, and limits the robustness and generalizability of pooled estimates.
“a limited number of contributing studies reduces statistical power, precision, restricts the ability to explore heterogeneity, and limits the robustness and generalizability of pooled estimates.”
Quote in the paperSubstantial claimMay combine two claims.
Study design and conductnone givenStudies used different instruments to assess burden, quality of life, depression, anxiety, and distress, and thresholds for outcomes were not uniform across studies.
“Studies used different instruments to assess burden, QoL, depression, anxiety, and distress, and thresholds for outcomes were not uniform across studies.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductnone givenThe review protocol was established prior to study screening and data extraction.
“the review protocol was established prior to study screening and data extraction.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing), S4 (based). May combine two claims.
Interpretationnone givenGlioma caregiving might be challenging as caregivers must manage not only physical dependency and treatment-related demands, but also progressive cognitive impairment, behavioural disturbance, communication difficulty, personality changes, and loss of decision-making capacity of the patients.
“However, glioma caregiving might be challenging as caregivers must manage not only physical dependency and treatment-related demands, but also progressive cognitive impairment, behavioural disturbance, communication difficulty, personality changes, and loss of decision-making capacity of the patients.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
PremisereasoningMeasurement variability is important in pooled analysis of prevalence, as it can influence both absolute estimates obtained within individual studies and comparability of results across studies.
“Such measurement variability is important in pooled analysis of prevalence, as it can influence both absolute estimates obtained within individual studies and comparability of results across studies.”
Quote in the paperNot a substantial claimMay combine two claims.
InterpretationreasoningTaken together, these findings suggest that glioma caregiving is not uniformly "worse" than caregiving in all other cancers, but it is likely to be uniquely complex and, in many settings, especially psychologically demanding.
“Taken together, these findings suggest that glioma caregiving is not uniformly “worse” than caregiving in all other cancers, but it is likely to be uniquely complex and, in many settings, especially psychologically demanding.”
Quote in the paperSubstantial claimMay combine two claims.
Interpretationown dataThe present synthesis is congruent with the general evidence base, but the notably high pooled distress and substantial burden estimates support the view that glioma caregiving can be uniquely challenging because of the additional neurocognitive, behavioural, and relational consequences of the disease.
“The present synthesis is congruent with this general evidence base, but the notably high pooled distress and substantial burden estimates support the view that glioma caregiving can be uniquely challenging because of the additional neurocognitive, behavioural, and relational consequences of the disease.”
Quote in the paperSubstantial claimMay combine two claims.
Study design and conductown dataStudy quality was mixed, and domain-level assessment showed that some of the included studies had important methodological limitations with respect to sample selection, comparability, and outcome ascertainment.
“Study quality was mixed, and domain-level assessment showed that some of the included studies had important methodological limitations with respect to sample selection, comparability, and outcome ascertainment.”
Quote in the paperSubstantial claim
The paper relies on this without support.
The magnitude of caregiver burden and QoL impairment in glioma caregiving, and the frequency of anxiety, depression, and distress, remain variably reported across studies using different instruments and sampling frames.
“Despite growing attention, the magnitude of caregiver burden and QoL impairment in glioma caregiving, as well as the frequency of related psychosocial outcomes such as anxiety, depression, and distress, remain variably reported across studies using different instruments and sampling frames.”
The paper relies on this without support.
The different screening instruments and thresholds used across included studies measure the same underlying constructs sufficiently to be pooled.
“depression, anxiety, and distress were assessed using different screening instruments across included studies.”
“Clinically significant outcomes were not defined using identical thresholds across the studies.”
“Studies used different instruments to assess burden, QoL, depression, anxiety, and distress, and thresholds for outcomes were not uniform across studies.”
Statistics recomputed
Every reported test result, recomputed from its test statistic and degrees of freedom. A result shows as not adding up only once an independent check has confirmed it.
- Consistentz = -0.45reported p = .655 · recomputed p = .653
“z = −0.45, p = .655”
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Self-check results appear here once an independent check has confirmed them.
Cites
The PRISMA 2020 statement: An updated guideline for reporting systematic reviews
Page, M. J., McKenzie, J. E., Bossuyt, P. M., Boutron, I., Hoffmann, T. C., Mulrow, C. D., Shamseer, L., Tetzlaff, J. M., Akl, E. A., Brennan, S. E., et al. (2021) · BMJ · doi:10.1136/bmj.n71 · Cited by 108,283 · see citing works
The PRISMA 2020 statement: An updated guideline for reporting systematic reviews
Page, M. J., McKenzie, J. E., Bossuyt, P. M., Boutron, I., Hoffmann, T. C., Mulrow, C. D., Shamseer, L., Tetzlaff, J. M., Akl, E. A., Brennan, S. E., et al. (2021) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2021.03.001 · Cited by 4,265 · see citing works
Glioblastoma and Other Primary Brain Malignancies in Adults
Schaff, L. R., & Mellinghoff, I. K. (2023) · JAMA · doi:10.1001/jama.2023.0023 · Cited by 1,338 · see citing works
Luchini, C., Stubbs, B., Solmi, M., & Veronese, N. (2017) · World Journal of Meta-Analysis · doi:10.13105/wjma.v5.i4.80 · Cited by 977 · see citing works
Dunbar, S. B., Khavjou, O., Bakas, T., Hunt, G. G., Kirch, R., Leib, A. R., Morrison, R. S., Poehler, D. C., Roger, V. L., & Whitsel, L. P. (2018) · Circulation · doi:10.1161/cir.0000000000000570 · Cited by 320 · see citing works
Understanding and supporting informal cancer caregivers
Molassiotis, A., & Wang, M. (2022) · Current Treatment Options in Oncology · doi:10.1007/s11864-022-00955-3 · Cited by 138 · cited 3× · see citing works
“32,33 However, glioma caregiving might be challenging as caregivers must manage not only physical dependency and treatment-related demands, but also progressive cognitive impairment, behavioural disturbance, communication difficulty, personality changes, and loss of decision-making capacity of the…”
Symptom management and quality of life in glioma patients
Boele, F. W., Klein, M., Reijneveld, J. C., Verdonck-de Leeuw, I. M., & Heimans, J. J. (2014) · CNS Oncology · doi:10.2217/cns.13.65 · Cited by 107 · cited 1× · see citing works
“20,28 Conversely, neuro-oncology literature suggests that glioma caregivers may experience a particularly distinctive form of burden because patient cognitive, behavioural, and communication changes can disrupt relationships, shared decision-making, and daily family functioning in ways that are…”
Group-Based Trajectory Modeling of Caregiver Psychological Distress Over Time
Choi, C.-W. J., Stone, R. A., Kim, K. H., Ren, D., Schulz, R., Given, C. W., Given, B. A., & Sherwood, P. R. (2012) · Annals of Behavioral Medicine · doi:10.1007/s12160-012-9371-8 · Cited by 84 · see citing works
Trad, W., Koh, E., Daher, M., Bailey, A., Kastelan, M., Legge, D. M., Fleet, M., Simpson, G. K., & Hovey, E. J. (2015) · Frontiers in Oncology · doi:10.3389/fonc.2015.00203 · Cited by 74 · see citing works
Psychosocial Care for the Caregivers of Primary Malignant Brain Tumor Patients
Wasner, M., Paal, P., & Borasio, G. D. (2013) · Journal of Social Work in End-of-Life & Palliative Care · doi:10.1080/15524256.2012.758605 · Cited by 73 · see citing works
Advance care planning in patients with primary malignant brain tumors: a systematic review
Song, K., Amatya, B., Voutier, C., & Khan, F. (2016) · Frontiers in Oncology · doi:10.3389/fonc.2016.00223 · Cited by 60 · cited 1× · see citing works
“12 In a multicentre retrospective study focusing on the last months of life in glioblastoma, caregivers reported low QoL alongside symptoms suggestive of burnout and a strong need for targeted psychological support and caregiver training.”
Systematic review and meta-analysis of prevalence of depression among caregivers of cancer patients
Pan, Y.-C., & Lin, Y.-S. (2022) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2022.817936 · Cited by 52 · cited 1× · see citing works
“30,31 This problem is more relevant in the present review, as depression, anxiety, and distress were assessed using different screening instruments across included studies.”
Królikowska, K., Błaszczak, K., Ławicki, S., Zajkowska, M., & Gudowska-Sawczuk, M. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms262412162 · Cited by 46 · see citing works
Long, A., Halkett, G. K. B., Lobb, E. A., Shaw, T., Hovey, E., & Nowak, A. K. (2016) · Neuro-Oncology Practice · doi:10.1093/nop/npv039 · Cited by 46 · see citing works
Paterson, C., Roberts, C., Li, J., Chapman, M., Strickland, K., Johnston, N., Law, E., Bacon, R., Turner, M., Mohanty, I., et al. (2024) · Journal of Cancer Survivorship · doi:10.1007/s11764-023-01401-5 · Cited by 41 · see citing works
Self-citationCoolbrandt, A., Sterckx, W., Clement, P., Borgenon, S., Decruyenaere, M., de Vleeschouwer, S., Mees, A., & Dierckx de Casterlé, B. (2015) · Cancer Nursing · doi:10.1097/ncc.0000000000000216 · Cited by 38 · cited 1× · see citing works
“7 Consistent caregiver burden might contribute to reduction in caregiver health-related quality of life (QoL), increased anxiety and depressive symptoms, sleep disruption, and reduced participation in employment and social activities.”
Renovanz, M., Maurer, D., Lahr, H., Weimann, E., Deininger, M., Wirtz, C. R., Ringel, F. A., Singer, S., & Coburger, J. (2018) · Frontiers in Neurology · doi:10.3389/fneur.2018.00763 · Cited by 35 · see citing works
Caregiver burden by treatment and clinical characteristics of patients with glioblastoma
Au, T. H., Willis, C., Reblin, M., Peters, K. B., Nghiemphu, P. L., Taylor, J. W., Colman, H., Cohen, A. L., Ormond, D. R., Chakravarti, A., et al. (2022) · Supportive Care in Cancer · doi:10.1007/s00520-021-06514-0 · Cited by 34 · see citing works
The Hidden Morbidity of Cancer
Saria, M. G., Nyamathi, A., Phillips, L. R., Stanton, A. L., Evangelista, L., Kesari, S., & Maliski, S. (2017) · Nursing Clinics of North America · doi:10.1016/j.cnur.2016.10.002 · Cited by 29 · cited 1× · see citing works
“26,27 The pooled burden prevalence in this review is broadly consistent with that literature, while the heterogeneity mirrors the diversity of caregiving contexts previously described.”
Assessing the quality of life among caregivers of patients with gliomas
Minaya Flores, P., Berbis, J., Chinot, & Auquier, P. (2014) · Neuro-Oncology Practice · doi:10.1093/nop/npu027 · Cited by 29 · see citing works
Jacobs, D., Kumthekar, P., Stell, B. V., Grimm, S. A., RADEMAKER, A. W., Rice, L., Chandler, J. P., Muro, K., Marymont, M. H., Helenowski, I., et al. (2014) · Neuro-Oncology Practice · doi:10.1093/nop/npu004 · Cited by 29 · see citing works
Sacher, M., Meixensberger, J., & Krupp, W. (2018) · Journal of Neuro-Oncology · doi:10.1007/s11060-018-2962-x · Cited by 25 · see citing works
Li, Q., Zhang, L., Chen, C., Gan, Y., Jiang, L., Li, S., Xiang, W., Ming, Y., Yang, C., & Zhou, J. (2022) · Journal of Clinical Neuroscience · doi:10.1016/j.jocn.2021.11.012 · Cited by 24 · cited 1× · see citing works
“9 Similar work in glioblastoma caregivers has also highlighted that burden is not uniform across clinical settings and might vary according to treatment phase and patient clinical characteristics.”
Heckel, M., Hoser, B., & Stiel, S. (2017) · Journal of Psychosocial Oncology · doi:10.1080/07347332.2017.1379046 · Cited by 22 · see citing works
Chen, D., Zhu, J., Xu, Q., Wang, F., Ji, C., Di, H., Yuan, P., Bai, X., & Chen, L. (2021) · Annals of Translational Medicine · doi:10.21037/atm-21-2761 · Cited by 22 · cited 2× · see citing works
“11,30 Prior studies in cancer caregiving consistently show that informal caregivers experience higher rates of anxiety, depressive symptoms, and reduced QoL compared with population norms, with burden influenced by caregiving intensity, financial toxicity, and perceived lack of support.”
The impact of functional dependence and related surgical complications on postoperative mortality
Clifton, J. C., Engoren, M., Shotwell, M. S., Martin, B. J., Clemens, E. M., Guillamondegui, O. D., & Freundlich, R. E. (2022) · Journal of Medical Systems · doi:10.1007/s10916-021-01779-8 · Cited by 16 · cited 2× · see citing works
“6 Due to these patient-related impairments and care demands, caregivers may develop “ caregiver burden, ” which is a multidimensional construct consisting of time dependence, physical strain, emotional distress, social restriction, and financial pressure.”
Caregiver perceptions of end-of-life care in patients with high-grade glioma
Fortunato, J. T., Van Harn, M., Haider, S. A., Phillips, J., & Walbert, T. (2021) · Neuro-Oncology Practice · doi:10.1093/nop/npaa077 · Cited by 16 · see citing works
Factors associated with psychological distress in caregivers of patients with malignant gliomas
Forst, D. A., Podgurski, A. F., Quain, K. M., Landay, S. L., Anand, M., Kaslow-Zieve, E., Mesa, M. M., Jacobs, J. M., Dietrich, J., Parsons, M. W., et al. (2022) · Supportive Care in Cancer · doi:10.1007/s00520-022-06989-5 · Cited by 16 · see citing works
Gulino, V., Brunasso, L., Avallone, C., Costa, V., Adorno, A. A., Lombardo, M. C., Tumbiolo, S., Iacopino, D. G., & Maugeri, R. (2024) · World Neurosurgery · doi:10.1016/j.wneu.2024.08.114 · Cited by 11 · see citing works
Well-being and coping: key aspects of unmet need of people living with glioma
Baddeley, E., Sivell, S., Retzer, A., Nelson, A., Bulbeck, H., Seddon, K., Grant, R., Adams, R., Watts, C., Aiyegbusi, O. L., et al. (2025) · Neuro-Oncology Practice · doi:10.1093/nop/npae127 · Cited by 6 · see citing works
(2009) · Neuro-Oncology · doi:10.1215/15228517-2009-034 · Cited by 5 · cited 1× · see citing works
“29 For depression and anxiety, pooled prevalence estimates indicate that clinically significant symptoms are frequent among glioma care-givers, reflecting a substantial mental health burden in this population.”
Mental health status and associated factors of caregivers of patients with malignant brain tumors
Sakurada, K., Sato, I., Ikeda, M., & Narita, Y. (2025) · Journal of Neuro-Oncology · doi:10.1007/s11060-025-04963-9 · Cited by 4 · cited 1× · see citing works
“8 Conceptually, caregiver outcomes in glioma may be understood as downstream consequences of patient-related neurological and functional impairment interacting with intensity, duration, and context of informal provision of care.”
Au, T. H., Willis, C., Reblin, M., et al. (2022) · Supportive Care in Cancer · doi:10.1007/s00520-021-06691-y
Flagged first, then by citations
Cited by
Sorted by citations
Segura-Galán, F., Gutiérrez‐Sánchez, B., López‐Martínez, C., & Casado, R. D. P. (2026) · Healthcare · doi:10.3390/healthcare14172765
“From a clinical standpoint, depressive symptoms and QoL likely exist within a bidirectional, mutually reinforcing feedback loop: chronic caregiving stress diminishes QoL and heightens vulnerability to depressive symptoms, which in turn further impairs subjective QoL [58–60].”
- Authors
- Wei, H., Zhang, S., Tao, S., Li, J., & Liu, X.
- Affiliations
- Capital Medical University (CN)
- Corresponding author
- Liu, Xiaonan
- Venue
- Asia-Pacific Journal of Oncology Nursing
- Publisher
- Elsevier BV
- Published
- 2026-12
- Volume
- 13
- Pages
- 100978
- ISSN
- 2347-5625 (ISSN-L)
- PMC
- PMC13241747
- OpenAlex
- W7161400235
- Semantic Scholar
- 1cc5f7e2ce658e473289028853dda41c6892f089
- Cited by
- 1
- References
- 24
- Citations by year
- 2026: 1
- FWCI
- 3.51
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Asia-Pacific Journal of Oncology Nursing (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- PubMed Central (submittedVersion, cc-by-nc-nd)
- Topics
- Health Sciences › Health Professions › Pharmacy › Nursing care and research
- Health Sciences › Medicine › Oncology › Cancer survivorship and care
- Social Sciences › Psychology › Clinical Psychology › Family Caregiving in Mental Illness
- Keywords
- caregiver burden, informal caregivers, glioma, quality of life, caregiver anxiety, caregiver depression, caregiver distress, psychosocial outcomes, neuro-oncology
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Claims read by deepseek-v4.1-flash under definition version 3 (extract-v3) on 2026-10-14.
Classified by jev-1.13-20260917 (gold-guideline-v0.2) on 2026-10-14.
Cited sources are checked by gpt-6-sol.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review